Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Olema Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 66
- −1 vs. Q4 2022
- Shares held
- 33.4M
- +81.2K (+0.2%) vs. Q4 2022
- Total value
- $116.1M
- +$34.5M (+42.2%) vs. Q4 2022
- New holders
- 7
- 19 more added
- Sold out
- 8
- 26 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OLMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 185 | $1.28B |
| Q1 2026 | 195 | $1.51B |
| Q4 2025 | 200 | $2.27B |
| Q3 2025 | 126 | $668.2M |
| Q2 2025 | 123 | $300.5M |
| Q1 2025 | 134 | $248.0M |
| Q4 2024 | 157 | $415.4M |
| Q3 2024 | 130 | $700.3M |
| Q2 2024 | 129 | $626.9M |
| Q1 2024 | 126 | $635.2M |
| Q4 2023 | 113 | $717.1M |
| Q3 2023 | 97 | $584.4M |
| Q2 2023 | 87 | $329.2M |
| Q1 2023 | 66 | $116.1M |
| Q4 2022 | 67 | $81.6M |
| Q3 2022 | 73 | $92.1M |
| Q2 2022 | 76 | $139.2M |
| Q1 2022 | 91 | $155.2M |
| Q4 2021 | 97 | $359.5M |
| Q3 2021 | 76 | $1.01B |
| Q2 2021 | 69 | $1.05B |
| Q1 2021 | 74 | $1.16B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Olema Pharmaceuticals, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 7,611,503 | $26.4M | 0.97% | 00.0% | Unchanged |
| Logos Global Management LP | 3,743,875 | $13.0M | 1.86% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 3,082,000 | $10.7M | 0.70% | +1,000,000+48.0% | Added |
| Paradigm Biocapital Advisors LP | 2,382,377 | $8.27M | 0.78% | +2,382,377 | New |
| Janus Henderson Group PLC | 2,085,179 | $7.28M | 0.00% | −972,127−31.8% | Reduced |
| Kynam Capital Management, LP | 2,011,853 | $6.98M | 0.90% | −13,381−0.7% | Reduced |
| Vivo Capital, LLC | 1,689,515 | $5.86M | 0.44% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,507,767 | $5.23M | 0.00% | +32,417+2.2% | Added |
| Citadel Advisors LLC | 1,230,516 | $4.27M | 0.00% | +5,366+0.4% | Added |
| BlackRock Inc. | 996,177 | $3.46M | 0.00% | −47,018−4.5% | Reduced |
| Sectoral Asset Management Inc | 995,909 | $3.46M | 0.66% | −445,896−30.9% | Reduced |
| Acadian Asset Management LLC | 575,900 | $2.00M | 0.01% | 00.0% | Unchanged |
| Laurion Capital Management LP | 513,972 | $1.78M | 0.08% | +18,672+3.8% | Added |
| J. Goldman & Co LP | 447,083 | $1.55M | 0.09% | −68,494−13.3% | Reduced |
| Adage Capital Partners GP, L.L.C. | 420,000 | $1.46M | 0.00% | 00.0% | Unchanged |
| Newtyn Management, LLC | 375,000 | $1.30M | 0.26% | +15,000+4.2% | Added |
| Geode Capital Management, LLC | 349,946 | $1.21M | 0.00% | +13,047+3.9% | Added |
| Vontobel Holding Ltd. | 337,917 | $1.17M | 0.01% | −188,896−35.9% | Reduced |
| Renaissance Technologies LLC | 257,200 | $892.0K | 0.00% | −9,000−3.4% | Reduced |
| Deutsche Bank AG | 254,718 | $883.9K | 0.00% | −201,948−44.2% | Reduced |
| Jacobs Levy Equity Management, Inc | 230,568 | $800.1K | 0.00% | +178,740+344.9% | Added |
| Gsa Capital Partners LLP | 230,632 | $800.0K | 0.08% | −1,001−0.4% | Reduced |
| Monaco Asset Management SAM | 221,905 | $770.0K | 0.35% | −129,612−36.9% | Reduced |
| Dimensional Fund Advisors LP | 213,312 | $740.2K | 0.00% | +46,379+27.8% | Added |
| Two Sigma Advisers, LP | 205,900 | $714.5K | 0.00% | −20,500−9.1% | Reduced |
| Walleye Capital LLC | 182,337 | $632.7K | 0.01% | +151,036+482.5% | Added |
| Two Sigma Investments, LP | 161,433 | $560.2K | 0.00% | −22,839−12.4% | Reduced |
| State Street Corp | 121,181 | $420.5K | 0.00% | +12,100+11.1% | Added |
| Bridgeway Capital Management, LLC | 115,687 | $401.4K | 0.01% | −22,000−16.0% | Reduced |
| Morgan Stanley | 113,890 | $395.2K | 0.00% | −89,032−43.9% | Reduced |
| Susquehanna International Group, LLP | 88,016 | $305.4K | 0.00% | +88,016 | New |
| Millennium Management LLC | 75,224 | $261.0K | 0.00% | −660,729−89.8% | Reduced |
| Northern Trust Corp | 72,992 | $253.3K | 0.00% | +5,374+7.9% | Added |
| Price T Rowe Associates Inc | 58,300 | $203.0K | 0.00% | −10,200−14.9% | Reduced |
| Jane Street Group, LLC | 55,370 | $192.1K | 0.00% | +43,964+385.4% | Added |
| Cornercap Investment Counsel Inc | 51,152 | $177.5K | 0.03% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 40,895 | $141.9K | 0.00% | +8,902+27.8% | Added |
| Man Group plc | – | $124.3K | 0.00% | – | New |
| Marshall Wace, LLP | 35,700 | $123.9K | 0.00% | −90,949−71.8% | Reduced |
| Bank of America Corp | 29,393 | $102.0K | 0.00% | +1,042+3.7% | Added |
| Tower Research Capital LLC (TRC) | 29,150 | $101.0K | 0.00% | +19,358+197.7% | Added |
| Conway Capital Management, Inc. | 26,500 | $92.0K | 0.08% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 23,943 | $83.1K | 0.00% | +23,943 | New |
| HRT Financial LP | 19,644 | $68.0K | 0.00% | +19,644 | New |
| Charles Schwab Investment Management Inc | 18,580 | $64.5K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 16,225 | $56.3K | 0.00% | −3,726−18.7% | Reduced |
| Cubist Systematic Strategies, LLC | 15,161 | $52.6K | 0.00% | +1,041+7.4% | Added |
| Tudor Investment Corp Et Al | 12,745 | $44.0K | 0.00% | −7,131−35.9% | Reduced |
| Algert Global LLC | 12,450 | $43.2K | 0.00% | −9,790−44.0% | Reduced |
| Bank of New York Mellon Corp | 12,200 | $42.3K | 0.00% | 00.0% | Unchanged |
| HSBC Holdings PLC | 10,150 | $37.1K | 0.00% | 00.0% | Unchanged |
| PDT Partners, LLC | 10,573 | $36.7K | 0.00% | −12,841−54.8% | Reduced |
| Virtu Financial LLC | 10,015 | $35.0K | 0.00% | −3,500−25.9% | Reduced |
| Citigroup Inc | 9,912 | $34.4K | 0.00% | +9,912 | New |
| Barclays PLC | 4,622 | $16.0K | 0.00% | +714+18.3% | Added |
| Federated Hermes, Inc. | 1,709 | $5.93K | 0.00% | −1,865−52.2% | Reduced |
| Truvestments Capital LLC | 1,323 | $4.59K | 0.00% | +1,323 | New |
| JPMorgan Chase & Co | 1,194 | $4.00K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 1,020 | $4.00K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 672 | $2.33K | 0.00% | −24−3.4% | Reduced |
| UBS Group AG | 356 | $1.24K | 0.00% | −3,732−91.3% | Reduced |
| Crewe Advisors LLC | 314 | $1.09K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 358 | $1.00K | 0.00% | +276+336.6% | Added |
| Wells Fargo & Company | 246 | $854 | 0.00% | +4+1.7% | Added |
| Newbridge Financial Services Group, Inc. | 28 | $97 | 0.00% | 00.0% | Unchanged |
| EP Wealth Advisors, LLC | 4,508 | – | – | −41,740−90.3% | Reduced |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −318,926−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −260,500−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −133,157−100.0% | Sold out |
| Anson Funds Management LP | 0 | $0 | 0.00% | −129,631−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −38,906−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −16,322−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −11,991−100.0% | Sold out |
| Running Point Capital Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |